Sugar Fix Keeps RIPK3 at Bay

Research output: Contribution to journalShort SurveyOtherpeer-review

Abstract

Immunometabolism is emerging as an important modulator of immune responses. In this issue of Immunity, Li et al. (2019) examine the link between lipopolysaccharide (LPS)-induced glucose metabolism and innate immune signaling and identify how β-N-acetylglucosamine (O-GlcNAc) modification of the RIPK3 RHIM domain limits inflammation and necroptosis.

Original languageEnglish
Pages (from-to)539-541
Number of pages3
JournalImmunity
Volume50
Issue number3
DOIs
Publication statusPublished - 19 Mar 2019

Cite this